Related content

Lack of in vivo mutagenicity and oxidative DNA damage by flumequine in the livers of gpt delta mice

By Kuroiwa Yuichi   Umemura Takashi   Nishikawa Akiyoshi   Kanki Keita   Ishii Yuji   Kodama Yukio   Masumura Ken-ichi   Nohmi Takehiko   Hirose Masao  

Archives of Toxicology, Vol. 81, Iss. 1, 2007-01 ,pp. : 63-69

Springer Publishing Company

Access to resources Recommend Favorite

In vivo modeling of human liver for pharmacological study using humanized mouse

By Yoshizato Katsutoshi   Tateno Chise  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 11, 2009-11 ,pp. : 1435-1446

Informa Healthcare

Access to resources Recommend Favorite

FOLFOX4 enhances surgery for resectable liver metastases

By  

Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Ultrasound Exposure Enhances the Biological Action of Interferon in the Liver

By Matsumura Takeshi   Moriyasu Fuminori   Toda Yasunobu   Kishi Kiyohiko   Chiba Tsutomu   Tabata Yasuhiko  

Journal of Drug Targeting, Vol. 10, Iss. 3, 2002-01 ,pp. : 205-209

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450-dependent n-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, -naphthoflavone and l-deprenyl

By Valoti M.   Fusi F.   Frosini M.   Pessina F.   Tipton K.F.   Sgaragli G.P.  

European Journal of Pharmacology, Vol. 391, Iss. 3, 2000-03 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite